Other surface markers, such as CD33, CD44, CD47, CD52, CD105, CD114, CD117, CD133, CD135, and CD184, were identified both in AML and CML LSCs but were also expressed on normal BM stem cells. Here, FLT3 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.